Anti-S12A3/ SLC12A3/ NCC monoclonal antibody

Anti-S12A3/ SLC12A3/ NCC antibody for FACS & in-vivo assay

Target products collectionGo to SLC12A3/SLC12A3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T84886-Ab-1/ GM-Tg-hg-T84886-Ab-2Anti-Human SLC12A3 monoclonal antibodyHuman
GM-Tg-rg-T84886-Ab-1/ GM-Tg-rg-T84886-Ab-2Anti-Rat SLC12A3 monoclonal antibodyRat
GM-Tg-mg-T84886-Ab-1/ GM-Tg-mg-T84886-Ab-2Anti-Mouse SLC12A3 monoclonal antibodyMouse
GM-Tg-cynog-T84886-Ab-1/ GM-Tg-cynog-T84886-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC12A3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T84886-Ab-1/ GM-Tg-felg-T84886-Ab-2Anti-Feline SLC12A3 monoclonal antibodyFeline
GM-Tg-cang-T84886-Ab-1/ GM-Tg-cang-T84886-Ab-2Anti-Canine SLC12A3 monoclonal antibodyCanine
GM-Tg-bovg-T84886-Ab-1/ GM-Tg-bovg-T84886-Ab-2Anti-Bovine SLC12A3 monoclonal antibodyBovine
GM-Tg-equg-T84886-Ab-1/ GM-Tg-equg-T84886-Ab-2Anti-Equine SLC12A3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T84886-Ab-1/ GM-Tg-hg-T84886-Ab-2; GM-Tg-rg-T84886-Ab-1/ GM-Tg-rg-T84886-Ab-2;
GM-Tg-mg-T84886-Ab-1/ GM-Tg-mg-T84886-Ab-2; GM-Tg-cynog-T84886-Ab-1/ GM-Tg-cynog-T84886-Ab-2;
GM-Tg-felg-T84886-Ab-1/ GM-Tg-felg-T84886-Ab-2; GM-Tg-cang-T84886-Ab-1/ GM-Tg-cang-T84886-Ab-2;
GM-Tg-bovg-T84886-Ab-1/ GM-Tg-bovg-T84886-Ab-2; GM-Tg-equg-T84886-Ab-1/ GM-Tg-equg-T84886-Ab-2
Products NameAnti-SLC12A3 monoclonal antibody
Formatmab
Target NameSLC12A3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC12A3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S12A3/ SLC12A3/ NCC VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001732human SLC12A3 Lentivirus plasmid
    ORF Viral VectorvGMLP001732human SLC12A3 Lentivirus particle


    Target information

    Target IDGM-T84886
    Target NameSLC12A3
    Gene ID6559,20497,54300,703090,478118,101082284,404171,100051953
    Gene Symbol and SynonymsNCC,NCCT,SLC12A3,TSC
    Uniprot AccessionP55017,P55018
    Uniprot Entry NameS12A3_HUMAN,S12A3_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000070915
    Target ClassificationN/A

    The target: SLC12A3, gene name: SLC12A3, also named as NCC, NCCT, TSC. This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.